摘要 |
There are disclosed new substituted triazolinone, triazolinethione, and triazolinimine compounds which are useful as angiotensin II antagonists. These compounds have the general formula: wherein: R1 is (a) -CO2R4, (b) -SO3R5, (c) -NHSO2CF3, (d) -PO(OR5)2, (e) -SO2-NH-R9, (f) -CONHOR5, (g) -SO2NH-heteroaryl, (h) -CH2SO2NH-heteroaryl, (i) -SO2NHCOR23, (j) -CH2SO2NHCOR23, (k)-CONHSO2R23, (l)-CH2CONHSO2R23, (m)-NHSO2NHCOR23, (n)-NHCONHSO2R23, <IMGS> (s) -CONHNNSO2CF3 <IMGS> wherein: heteroaryl is an unsubstituted, monosubstituted or disubstituted 5- or 6-membered aromatic ring which contains from 1 to 3 heteroatoms selected from the group consisting of O, N and S and wherein the substituents are members selected from the group consisting of -OH, -SH, C1-C4-alkyl, C1-C4-alkoxy, -CF3, halo (Cl, Br, F, I), -NO2, -CO2H, -CO2-C1-C4-alkyl, -NH2, -NH (C1-C4-alkyl) or -N(C1-C4-alkyl)2.
|
申请人 |
|
发明人 |
ASHTON, WALLACE T.;CHANG, LINDA L.;WALSH, THOMAS F.;PATCHETT, ARTHUR A.;GREENLEE, WILLIAM J.;CHAKRAVARTY, PRASUN K.;MACCOSS, MALCOLM |